These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 16165377)
1. Response to: identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20. Burns JW; Kraines JL; Magilavy DB; Murray CW; Richards SM Osteoarthritis Cartilage; 2005 Dec; 13(12):1128-9; author reply 1130-1. PubMed ID: 16165377 [No Abstract] [Full Text] [Related]
2. Identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20. Hamburger M; Settles M; Teutsch J Osteoarthritis Cartilage; 2005 Mar; 13(3):266-8. PubMed ID: 15727894 [No Abstract] [Full Text] [Related]
3. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part I. Magilavy D; Polisson R; Murray C J Bone Joint Surg Am; 2003 Aug; 85(8):1618-9; author reply 1619-20. PubMed ID: 12925653 [No Abstract] [Full Text] [Related]
4. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part II. Waddell DD J Bone Joint Surg Am; 2003 Aug; 85(8):1620; author reply 1620-1. PubMed ID: 12925654 [No Abstract] [Full Text] [Related]
5. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms. Li P; Raitcheva D; Hawes M; Moran N; Yu X; Wang F; Matthews GL Osteoarthritis Cartilage; 2012 Nov; 20(11):1336-46. PubMed ID: 22809835 [TBL] [Abstract][Full Text] [Related]
6. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. Adams ME J Rheumatol; 1996 May; 23(5):944-5; author reply 946. PubMed ID: 8724316 [No Abstract] [Full Text] [Related]
7. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. O'Hanlon D J Rheumatol; 1996 May; 23(5):945-6. PubMed ID: 8724318 [No Abstract] [Full Text] [Related]
8. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. Puttick MP; Wade JP; Chalmers A; Connell DG; Rangno KK J Rheumatol; 1995 Jul; 22(7):1311-4. PubMed ID: 7562764 [TBL] [Abstract][Full Text] [Related]
9. The effects of high molecular weight hyaluronic acid (Hylan G-F 20) on experimentally induced temporomandibular joint osteoartrosis: part II. Duygu G; Güler N; Cam B; Kürkçü M Int J Oral Maxillofac Surg; 2011 Dec; 40(12):1406-13. PubMed ID: 21889876 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial. Munteanu SE; Zammit GV; Menz HB; Landorf KB; Handley CJ; Elzarka A; Deluca J Ann Rheum Dis; 2011 Oct; 70(10):1838-41. PubMed ID: 21791454 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study. Brander VA; Gomberawalla A; Chambers M; Bowen M; Nuber G PM R; 2010 Apr; 2(4):259-67. PubMed ID: 20430327 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis. Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of hylan g-f 20 in Guinea pigs and mice. Sasaki M; Miyazaki T; Nakamura T; Takahashi T; Miyauchi S; Iwata H J Rheumatol; 2004 May; 31(5):943-50. PubMed ID: 15124255 [TBL] [Abstract][Full Text] [Related]
15. Acute inflammation with induction of anaphylatoxin C5a and terminal complement complex C5b-9 associated with multiple intra-articular injections of hylan G-F 20: a case report. Dragomir CL; Scott JL; Perino G; Adler R; Fealy S; Goldring MB Osteoarthritis Cartilage; 2012 Jul; 20(7):791-5. PubMed ID: 22484575 [TBL] [Abstract][Full Text] [Related]
16. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928 [TBL] [Abstract][Full Text] [Related]
18. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Kemper F; Gebhardt U; Meng T; Murray C Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536 [TBL] [Abstract][Full Text] [Related]
19. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report. Yustin D; Kryshtalskyj B; Galea A J Orofac Pain; 1995; 9(4):375-9. PubMed ID: 8995909 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model. Ottaviani RA; Wooley P; Song Z; Markel DC J Bone Joint Surg Am; 2007 Jan; 89(1):148-57. PubMed ID: 17200322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]